Suraj Kalia

Healthcare

Limited coverage. Only 3 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.

2

Companies

3

Questions

0%

Challenge RatePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.

Challenge Trend

Q3 '24Q3 '25

Focus Areas6 topics

Product Launch1Innovation & R&D1Capital Allocation1Trade Tariffs1Competitive Dynamics1Pricing1

Trends3 quarters

Questions per Quarter

Questions

Challenging

Companies Covered

Question History3 questions

ABTAbbott Laboratories1 quarter

2025 Q3

Would love to get your thoughts specifically on the mitral and tricuspid US TAM

Product LaunchInnovation & R&DView in transcript →

RMDResMed2 quarters

2025 Q1

Could you talk to the confidence in doing that in light of the demand environment you're seeing, just given some of the uncertainty now with tariffs

Capital AllocationTrade TariffsView in transcript →

2024 Q3

how would you say ResMed is buffered from a potentially more price-sensitive environment if and when Philips returns

Competitive DynamicsPricingView in transcript →